Agilent Technologies (United Kingdom)
Agilent Technologies (United Kingdom)
Funder
35 Projects, page 1 of 7
assignment_turned_in Project2010 - 2014Partners:University of Bristol, ENEA, EADS DEUTSCHLAND GMBH, IMP-PAN, EUROPEAN AERONAUTIC DEFENCE AND SPACE COMPANY EADS FRANCE SAS +10 partnersUniversity of Bristol,ENEA,EADS DEUTSCHLAND GMBH,IMP-PAN,EUROPEAN AERONAUTIC DEFENCE AND SPACE COMPANY EADS FRANCE SAS,AIRBUS OPERATIONS GMBH,EASN-TIS,CNRS,Agilent Technologies (United Kingdom),EPFL,University of Patras,IRE NASU,RECENDT,A2,FHGFunder: European Commission Project Code: 266226more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2025 - 2028Partners:THE REVENUE COMMISSIONERS, INTA, SATWAYS, ANALYZE IQ LIMITED, NATIONAL TAX AND CUSTOMS ADMINISTRATION +10 partnersTHE REVENUE COMMISSIONERS,INTA,SATWAYS,ANALYZE IQ LIMITED,NATIONAL TAX AND CUSTOMS ADMINISTRATION,CBRA SERVICES,Agilent Technologies (United Kingdom),Rapita Systems (United Kingdom),HO,RSOE,TU Delft,VICESSE,TOLLREGION OSLO OG AKERSHUS,UG,REZEROFunder: European Commission Project Code: 101167589Funder Contribution: 5,720,120 EUREU customs administrations implement common rules at the EU Customs Union borders. They protect society while facilitating legitimate trade. Alongside the collection of duties and taxes, customs core activities now include security related roles including fighting illegal trade in drugs, weapons, radioactive and nuclear materials, security sensitive dual-use items, illicit waste and other environmental threats. To deal with high volumes of goods moving across the Union`s borders, and the need to restrict physical interventions to a minimum, customs operate a risk-based, multi-level detection architecture at Border Crossing Points. This must take into account the nature of the operational environment, the threat materials to be detected, and the types of concealments used by smugglers. For more than two decades, customs have used X-ray scanning as a first level control. However, current applications of this technology continue to result in a relatively high level of false positives/negatives and inconclusive results, giving rise to secondary controls, including physical inspections. This can be attributed in part to a failure to develop operator skills through accredited training and sharing of images of threat materials and concealments in a structured manner. Moreover, second level technology controls such as Raman spectroscopy are frequently applied with a narrow focus. The EU Customs Control Equipment Instrument aims to harmonize customs controls at the EU borders and to upgrade customs equipment including X-ray scanners and field analysis devices. BORDERLINK aims to make a significant contribution to CCEI aims as well as the planned reform of the Customs Union. BORDERLINK will enhance customs` capabilities and performance at EU borders by advancing the detection and identification of threat materials, improving training, communication and data sharing. It will help to strengthen supply chain controls and promote the Green Customs Initiative.
more_vert assignment_turned_in Project2006 - 2007Partners:Agilent Technologies Ltd, Agilent Technologies UK Ltd, University of Leicester, Agilent Technologies (United Kingdom), University of LeicesterAgilent Technologies Ltd,Agilent Technologies UK Ltd,University of Leicester,Agilent Technologies (United Kingdom),University of LeicesterFunder: UK Research and Innovation Project Code: BB/D524416/1Funder Contribution: 71,500 GBPAbstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
more_vert assignment_turned_in Project2014 - 2017Partners:University of Edinburgh, National High Magnetic Field Laboratory, ISIS Facility, Agilent Technologies UK Ltd, Agilent Technologies (United Kingdom) +12 partnersUniversity of Edinburgh,National High Magnetic Field Laboratory,ISIS Facility,Agilent Technologies UK Ltd,Agilent Technologies (United Kingdom),University of Cantabria,Cambridge Crystallographic Data Centre,UC,Easy-Lab,Science and Technology Facilities Council,CCDC,National High Magnetic Field Laboratory,KU Leuven,University of Leuven,University of Leuven,Easy-Lab,ISIS FacilityFunder: UK Research and Innovation Project Code: EP/K033646/1Funder Contribution: 767,232 GBPIn optimizing the properties of functional materials it is essential to understand in detail how structure influences properties. Identification of the most important structural parameters is time-consuming and usually investigated by preparing many different chemical modifications of a material, determining their crystal structures, measuring their physical properties and then looking for structure-property correlations. It is also necessary to assume that the chemical modifications have no influence other than to distort the structure, which is often not the case. High pressure offers a way around these difficulties. Pressure can be used to distort a material without the need for chemical modification. Both crystal structures and physical property measurements can be conducted at high pressure, so that the properties of the same material can be studied in different states of distortion, providing the most direct way to study correlations between structure and properties. In this proposal we focus on structure-property relationships in molecule-based magnets connected into extended chains, networks or frameworks using a combination of high pressure crystallography, magnetic measurements, spectroscopy and simulation which will exploit the UK's unique capabilities in extreme conditions research. Extended materials are of great interest because a small distortion at one site is propagated throughout the material by the strong chemical links between the magnetic centres, making the magnetic properties very sensitive to structural changes. We will design and build new instruments for magnetic susceptibility and diffraction measurements at high pressure and low temperature and we will exploit these new instruments and methodology to study two important classes of magnetic material. 1-D magnetic materials represent a fertile playground for discovering and understanding exotic physical phenomena. The magnetic behaviour of Single-Chain Magnets (SCMs) is fundamentally governed by the magnitude of nearest neighbour exchange interactions (intra-chain exchange), the extent of inter-chain interactions, and Ising-like anisotropy - all of which are sensitive to pressure. We have already shown that these parameters can be pressure-tuned in Single-Molecule Magnets (SMMs) and the same should be true for SCMs In 3-D frameworks magnetism can be combined with porosity, so that inclusion of different guest molecules provides another means for controlling magnetic properties. Prussian Blue Analogues consist of different metal cations linked by cyanide anions, while metal carboxylates build diamond-like frameworks. In both cases guest molecules influence magnetic ordering temperatures. Some metal-organic frameworks show spin-crossover behaviour, where different electronic configurations of the metal ions are stable under different conditions. The transition from one form to another is influenced by guest molecules which occupy the pores of the framework. High pressure will enable us to control the structure of the framework itself, the interactions between the host and the guest, and the number of guest molecules incorporated into the pores, providing a quantitative link between host-guest interactions and magnetism.
more_vert assignment_turned_in Project2014 - 2023Partners:INRA Sophia Antipolis, UCL, Lightpoint Medical Ltd, MR Solutions Limited, Bruker UK Ltd +112 partnersINRA Sophia Antipolis,UCL,Lightpoint Medical Ltd,MR Solutions Limited,Bruker UK Ltd,GE Aviation,Hamamatsu Photonics UK Ltd,Lightpoint Medical Ltd,Dexela Ltd,Blackford Analysis Ltd,Microsoft Research,Samsung Advanced Institute of Technology,Fujifilm Visualsonics Inc,Agilent Technologies UK Ltd,Siemens AG,The Francis Crick Institute,Philips Healthcare,Medtronic,Wolfson Foundation,Mirada Solutions,Millennium the Takeda Oncology Company,Pelican Cancer Foundation,Olea Medical,WF,Hvidovre Hospital,ESI Group,Netherlands Cancer Institute,UU,University of Pennsylvania,Creatv MicroTech (United States),Alzheimer's Society,University College Hospital,Siemens AG (International),Alzheimer's Research UK,Pulseteq Ltd,The Huntington's Disease Association,Agilent Technologies (United Kingdom),Precision Acoustics (United Kingdom),icometrix,Mediso,The Francis Crick Institute,Hitachi Ltd,Netherlands Cancer Institute,Teraview Ltd,Blackford Analysis Ltd,PerkinElmer (United Kingdom),IXICO Ltd,Philips Healthcare (Global),MRC National Inst for Medical Research,Elekta UK Ltd,Elekta UK Ltd,JPK Instruments Limited,Brain Products GmbH,Pelican Cancer Foundation,Medtronic,Alzheimer's Society,Moorfields Eye Hosp NHS Foundation Trust,Dexela Ltd,GE Healthcare,Creatv MicroTech,Cancer Research UK,Samsung Advanced Institute of Technology,Child Health Research Appeal Trust,Microsoft Research,RENISHAW,Alzheimer's Research UK,Child Health Research Appeal Trust,The Huntington's Disease Association,GE Healthcare,Yale University,Danish Research Centre for Magnetic Reso,Rigaku,Yale University,RAPID Biomedical GmbH,icoMetrix,Great Ormond Street Hospital,Olea Medical,CANCER RESEARCH UK,Hitachi Ltd,Bruker UK Ltd,Fujifilm Visualsonics Inc,Beijing Normal University,Danish Research Centre for Magnetic Reso,University of Pennsylvania,TeraView Limited,Beijing Normal University,Moorfields Eye NHS Foundation Trust,Renishaw plc (UK),Siemens,Siemens AG,Great Ormond Street Hospital Children's Charity,Vision RT Ltd,Imaging Equipment Ltd,Imperial Cancer Research Fund,Imaging Equipment Limited,PULSETEQ LTD,Precision Acoustics Ltd,MR Solutions Limited,Philips (Netherlands),RAPID Biomedical GmbH,Mirada Solutions,University of Utah,Mediso,Agility Design Solutions,Agency for Science Technology-A Star,Millennium the Takeda Oncology Company,University College London Hospital (UCLH) NHS Foundation Trust,Hamamatsu Photonics UK Ltd,IXICO Technologies Ltd,University College London Hospitals,Brain Products GmbH,Teraview Ltd,Agency for Science Technology (A Star),Diameter Ltd,Rigaku,ESI Group,Vision RT LtdFunder: UK Research and Innovation Project Code: EP/L016478/1Funder Contribution: 5,797,790 GBPMedical imaging has transformed clinical medicine in the last 40 years. Diagnostic imaging provides the means to probe the structure and function of the human body without having to cut open the body to see disease or injury. Imaging is sensitive to changes associated with the early stages of cancer allowing detection of disease at a sufficient early stage to have a major impact on long-term survival. Combining imaging with therapy delivery and surgery enables 3D imaging to be used for guidance, i.e. minimising harm to surrounding tissue and increasing the likelihood of a successful outcome. The UK has consistently been at the forefront of many of these developments. Despite these advances we still do not know the most basic mechanisms and aetiology of many of the most disabling and dangerous diseases. Cancer survival remains stubbornly low for many of the most common cancers such as lung, head and neck, liver, pancreas. Some of the most distressing neurological disorders such as the dementias, multiple sclerosis, epilepsy and some of the more common brain cancers, still have woefully poor long term cure rates. Imaging is the primary means of diagnosis and for studying disease progression and response to treatment. To fully achieve its potential imaging needs to be coupled with computational modelling of biological function and its relationship to tissue structure at multiple scales. The advent of powerful computing has opened up exciting opportunities to better understand disease initiation and progression and to guide and assess the effectiveness of therapies. Meanwhile novel imaging methods, such as photoacoustics, and combinations of technologies such as simultaneous PET and MRI, have created entirely new ways of looking at healthy function and disturbances to normal function associated with early and late disease progression. It is becoming increasingly clear that a multi-parameter, multi-scale and multi-sensor approach combining advanced sensor design with advanced computational methods in image formation and biological systems modelling is the way forward. The EPSRC Centre for Doctoral Training in Medical Imaging will provide comprehensive and integrative doctoral training in imaging sciences and methods. The programme has a strong focus on new image acquisition technologies, novel data analysis methods and integration with computational modelling. This will be a 4-year PhD programme designed to prepare students for successful careers in academia, industry and the healthcare sector. It comprises an MRes year in which the student will gain core competencies in this rapidly developing field, plus the skills to innovate both with imaging devices and with computational methods. During the PhD (years 2 to 4) the student will undertake an in-depth study of an aspect of medical imaging and its application to healthcare and will seek innovative solutions to challenging problems. Most projects will be strongly multi-disciplinary with a principle supervisor being a computer scientist, physicist, mathematician or engineer, a second supervisor from a clinical or life science background, and an industrial supervisor when required. Each project will lie in the EPSRC's remit. The Centre will comprise 72 students at its peak after 4 years and will be obtaining dedicated space and facilities. The participating departments are strongly supportive of this initiative and will encourage new academic appointees to actively participate in its delivery. The Centre will fill a significant skills gap that has been identified and our graduates will have a major impact in academic research in his area, industrial developments including attracting inward investment and driving forward start-ups, and in advocacy of this important and expanding area of medical engineering.
more_vert
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right
